Medicare Enrolled
Dr. Wesley Ekeruo, MD
Urology Physician · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ekeruo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ekeruo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ekeruo
Dr. Wesley Ekeruo is an urology physician in Houston, TX, with 15 years of NPI registration. Based on federal Medicare data, Dr. Ekeruo performed 1,173 Medicare services across 1,012 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ekeruo received a total of $23,627 from 54 pharmaceutical and/or device companies across 255 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ekeruo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ 1,173 Medicare services
$23,627 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,173
Medicare services
Bottom 39% in TX for urology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
1,012
Unique beneficiaries
$130
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~78 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
369 | $60 | $212 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
128 | $87 | $314 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
85 | $110 | $483 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 78 | $136 | $734 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
77 | $190 | $1,081 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
42 | $8 | $112 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
41 | $111 | $498 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $128 | $421 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
32 | $100 | $401 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
27 | $187 | $1,186 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
26 | $73 | $317 |
| Laparoscopic partial prostate removal A minimally invasive surgical procedure to remove part of the prostate gland using a laparoscope. |
25 | $613 | $4,085 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
24 | $20 | $663 |
| Injection, garamycin, gentamicin, up to 80 mg | 22 | $2 | $3 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
21 | $331 | $2,074 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
20 | $61 | $296 |
| Endoscopic removal of pelvic lymph nodes, bilateral A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue. |
18 | $231 | $3,721 |
| Suture suspension of urethra to control leakage using an endoscope A surgical procedure that uses an endoscope to place sutures that suspend the urethra in order to control urinary leakage. |
18 | $259 | $3,450 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
18 | $829 | $8,159 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
17 | $567 | $4,340 |
| Nerve repair with graft A surgical procedure to repair a damaged nerve by using a graft to bridge the gap between the severed ends. |
16 | $279 | $3,787 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
13 | $25 | $146 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
12 | $88 | $302 |
| New patient office visit, complex (60-74 min) | 11 | $162 | $600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.8% high complexity
14.4% medium
83.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$23,627
Total received (2018-2024)
Avg $3,375/year across 7 years
Top 10% in TX for urology physician
54
Companies
255
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$11,678 (49.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,215 (30.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,735 (20.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,327
2023
$4,833
2022
$4,425
2021
$4,716
2020
$2,028
2019
$4,173
2018
$2,125
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Coloplast Corp
$9,607
COLOPLAST CORP
$4,625
Intuitive Surgical, Inc.
$2,834
Boston Scientific Corporation
$1,636
Abbott Laboratories
$584
BOSTON SCIENTIFIC CORPORATION
$531
Endo Pharmaceuticals Inc.
$394
PFIZER INC.
$384
Astellas Pharma US Inc
$337
BIOTISSUE HOLDINGS INC.
$326
NeoTract Inc.
$249
INTUITIVE SURGICAL, INC.
$213
NxThera, Inc.
$163
PROCEPT BioRobotics Corporation
$138
Janssen Biotech, Inc.
$132
Dendreon Pharmaceuticals LLC
$119
Terumo Medical Corporation
$111
Avadel Specialty Pharmaceuticals, LLC
$90
Merck Sharp & Dohme LLC
$79
ABBVIE INC.
$79
Edap Technomed Inc
$72
AbbVie, Inc.
$64
ConvaTec Inc.
$62
Ethicon US, LLC
$60
Axonics, Inc.
$57
Myriad Genetic Laboratories, Inc.
$50
Egalet US Inc
$50
Tolmar, Inc.
$46
Blue Earth Diagnostics Limited
$40
Teleflex LLC
$40
Olympus America Inc.
$30
Ferring Pharmaceuticals Inc.
$29
Allergan, Inc.
$28
DENTSPLY IH Inc.
$28
180 Medical, Inc.
$25
Medtronic, Inc.
$23
Retrophin, Inc.
$23
Antares Pharma, Inc.
$23
Pacira Pharmaceuticals Incorporated
$23
Alafair Biosciences, Inc.
$22
UROVANT SCIENCES INC
$20
Zyla Life Sciences
$19
Mission Pharmacal Company
$19
Travere Therapeutics, Inc.
$17
Novo Nordisk Inc
$16
Amgen Inc.
$14
C. R. Bard, Inc. & Subsidiaries
$14
BIOTISSUE HOLDINGS, INC.
$13
AKRIMAX PHARMACEUTICALS, LLC
$13
Bayer HealthCare Pharmaceuticals Inc.
$12
RGH Enterprises, Inc.
$12
Acerus Pharmaceuticals Corporation
$12
Allergan Inc.
$10
Ambu Inc.
$10
Top 3 companies account for 72.2% of total payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · ALTIS · AMS · AMS 700 · AVEED · AVEIR · AXIS · AZUR CX DETACHABLE · Altis · Androgel · AquaBeam Robotic System · Axonics · Axumin · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · CURE CATHETER · Coloplast TFL Drive · Confirm Rx · DA VINCI SP · Da Vinci Surgical System · ECHELON ENDOPATH · EDEX · ELIGARD · ERLEADA · EVICEL · Erleada · Exparel · FEMALE INCONTINENCE · GEMTESA · GENERAL DBS · GENERAL BPH · GENERAL FEMALE SUI · GENERAL - BPH · GENERAL BPH · GENERAL ERECTILE DYSFUNCTION · GENERAL FEMALE SUI · GENTLECATH · General - Therapies · INLAY OPTIMA · JOT DX · KEYTRUDA · LUPRON DEPOT · LoFric · Lupron Depot · MYRBETRIQ · Moses 550 DFL · Myrbetriq · NEOX · Natesto · Noctiva · Nubeqa · Olympus Laser Devices · Ozempic · PROLARIS · PROVENGE · Prolia · RESTORELLE · Rezum · Rezum Generator · SIGNIA · SPRIX · SpeediCath · Stendra · TACTRA · TESTOPEL · TOVIAZ · Thiola · Titan · UROLIFT · Uribel · UroLift · VESICARE · VISTASEAL Fibrin Sealant (Human) · VersaWrap · Vortek · Vortek Hydro · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (49%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for urology physician in TX.
Equivalent to $2,014 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
188
Per 100K population
4.0
County median income
$73,104
Nearest hospital
HOUSTON METHODIST WEST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ekeruo is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 10% of TX peers, with 15 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ekeruo experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Ekeruo performed 369 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ekeruo receive payments from pharmaceutical companies?
Yes. Dr. Ekeruo received a total of $23,627 from 54 companies across 255 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ekeruo's costs compare to other urology physicians in Houston?
Dr. Ekeruo's average Medicare payment per service is $130. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ekeruo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Houston
Browse urology physicians in Houston ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
COLOPLAST CORP Payments to Doctors
See all physicians who received payments from COLOPLAST CORP.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology